U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07103174) titled 'A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis' on June 30.
Brief Summary: This study is a multicenter, randomized, double-blind, parallel controlled phase II study. It is planned to include approximately 60 subjects with moderate to severe atopic dermatitis(AD) to evaluate the efficacy and safety of MG-K10 monotherapy in adult patients with moderate to severe AD, and to observe PK characteristics, PD effects and immunogenicity.
Study Start Date: Aug. 16
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis (AD)
Intervention:
BIOLOGICAL: MG-K10 placebo
Administer the drug once ev...